How many insider trades does FilingIQ track for BRTX?

FilingIQ tracks 306 Form 4 insider transactions for BRTX (BioRestorative Therapies, Inc.), covering filings from Dec 30, 2013 onwards. 0 of those were filed in the last 90 days.

Are BRTX insiders net buyers or net sellers?

Across the full Form 4 history for BRTX, 225 transactions (74%) were open-market purchases and 9 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BRTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BRTX in?

BioRestorative Therapies, Inc. (BRTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $5.53M.

BRTX insider trading

NasdaqCM Healthcare

BioRestorative Therapies, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

306

Last 90 days

Buys / sells

74% / 3%

Market cap

$5.53M

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. It also operates a commercial biocosmeceutical platform. In addition, the company provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.

Company website: www.biorestorative.com

BRTX insider activity at a glance

FilingIQ has scored 306 insider transactions for BRTX since Dec 30, 2013. The most recent filing in our index is dated Oct 6, 2025.

Across the full history, 225 open-market purchases and 9 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BRTX insider trades is 52.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BRTX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for BRTX?: FilingIQ tracks 306 Form 4 insider transactions for BRTX (BioRestorative Therapies, Inc.), covering filings from Dec 30, 2013 onwards. 0 of those were filed in the last 90 days.
Are BRTX insiders net buyers or net sellers?: Across the full Form 4 history for BRTX, 225 transactions (74%) were open-market purchases and 9 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BRTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BRTX in?: BioRestorative Therapies, Inc. (BRTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $5.53M.

Methodology & sources

Every BRTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.